Download: Kinapse on New Data Analytics for Pharma and Healthcare

An interview with Stephen Doogan on data integration and analytics for drug evaluation and patient experience McKinsey has predicted big data could reduce research and development costs for pharmaceutical makers by $40 billion to $70 billion. New analytics strategies are now changing companies’ ability to integrate, harmonize, derive and cross-validate insights from disconnected data at scale. Pharma companies who team up with …